Search Page
Save citations to file
Email citations
Send citations to clipboard
Add to Collections
Add to My Bibliography
Create a file for external citation management software
Your saved search
Your RSS Feed
Filters
Results by year
Table representation of search results timeline featuring number of search results per year.
Year | Number of Results |
---|---|
2023 | 2 |
2024 | 1 |
Search Results
3 results
Results by year
Filters applied: . Clear all
It looks like you are searching for an author.
Results are currently sorted by Best Match. To see the newest results first,
change the sort order to Most Recent.
Page 1
Metabolic-Dysfunction-Associated Steatotic Liver Disease-Its Pathophysiology, Association with Atherosclerosis and Cardiovascular Disease, and Treatments.
Int J Mol Sci. 2023 Oct 23;24(20):15473. doi: 10.3390/ijms242015473.
Int J Mol Sci. 2023.
PMID: 37895151
Free PMC article.
Review.
A Possible Therapeutic Application of the Selective Inhibitor of Urate Transporter 1, Dotinurad, for Metabolic Syndrome, Chronic Kidney Disease, and Cardiovascular Disease.
Yanai H, Adachi H, Hakoshima M, Iida S, Katsuyama H.
Yanai H, et al. Among authors: iida s.
Cells. 2024 Mar 4;13(5):450. doi: 10.3390/cells13050450.
Cells. 2024.
PMID: 38474414
Free PMC article.
Review.
Item in Clipboard
Real-World Efficacy of Glucagon-like Peptide-1 (GLP-1) Receptor Agonist, Dulaglutide, on Metabolic Parameters in Japanese Patients with Type 2 Diabetes: A Retrospective Longitudinal Study.
Katsuyama H, Hakoshima M, Umeyama S, Iida S, Adachi H, Yanai H.
Katsuyama H, et al. Among authors: iida s.
Biomedicines. 2023 Mar 13;11(3):869. doi: 10.3390/biomedicines11030869.
Biomedicines. 2023.
PMID: 36979848
Free PMC article.
Item in Clipboard
Cite
Cite